A Rare Case of Late Onset Familial Long QT Syndrome Presented with Recurrent Cardiac Arrest, Complete Heart Block, and NSTEMI
Keywords:
Familial Long QT syndrome, cardiac arrest, myocardial infarction, cardiac pace makerAbstract
Long QT Syndrome (LQTS) is a rare cardiac condition whose etiology is acquired or congenital. It has a wide range of clinical manifestations ranging from asymptomatic to sudden cardiac death due to malignant arrhythmia such as ventricular tachycardia. Congenital LQTS usually occurs at an early age in the form of prolonged QT interval in ECG examination, but such a condition may occur in later life. Therefore, QT interval should be assessed thoroughly to minimize the risk of iatrogenic ventricular tachycardia. A 72-year-old Javanese female with recurrent syncope episodes for 8 months was referred to the emergency department for temporary pacemaker implantation due to a complete heart block and NSTEMI. Family history revealed a first-degree family history of sudden cardiac death. She had a history of recurrent cardiac arrest due to ventricular arrhythmia and was treated with amiodarone continuous intravenous infusion in the previous hospital. During examination in the emergency department, she experienced another episode of cardiac arrest due to ventricular arrhythmia. Electrocardiogram examination pre-cardiac arrest revealed a complete heart block, atrial rate 60 bpm, ventricle rate 60 bpm, T Inversion in I, aVL, V2-V6, with prolonged QT interval (QT 616 ms, QTc 578 ms). Thus, amiodarone was subsequently stopped, and defibrillation was administered under ACLS guidelines. After the return of spontaneous circulation, revascularization was conducted due to ongoing typical chest pain and increased troponin level (117 ng/mL) to the LAD. Despite optimal revascularization and normal electrolyte level (Sodium 137 mEq/L, Potassium 3.8 mEq/L, Chloride 104.5 mEq/L), prolonged QT interval was observed in the patient until the 9th day post-revascularization and the double-chamber pacemaker implantation was conducted on patient. Thus, the prolonged QT interval subsided after double-chamber pacemaker implantation. Long QT Syndrome may occur at any period of life and may be asymptomatic. A thorough ECG examination before commencing treatment on a patient was pivotal to preventing malignant arrhythmia.References
Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q- T interval and sudden death. Am Heart J. 1957;54(1):59-68.
Medeiros-Domingo A, Iturralde-Torres P, Ackerman MJ. Clinical and genetic characteristics of long QT syndrome. Revista Española de Cardiología (English Edition). 2007;6(7):739-52.
Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol. 2000;36(1):1-12.
Schwartz PJ. The congenital long QT syndromes from genotype to phenotype: clinical implications.Journal of Internal Medicine. 2006;259(1):39-47.
Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM. Causes and management of drug-induced long QT syndrome. Proc (Bayl Univ Med Cent). 2010;23(3):250-5.
Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. New England Journal of Medicine. 2003;348(19):1866-74.
Amoni M, Dries E, Ingelaere S, et al. Ventricular arrhythmias in ischemic cardiomyopathy-new avenues for mechanism-guided treatment. Cells. 2021;10(10).
Bui AH, Waks JW. Risk stratification of sudden cardiac death after acute myocardial infarction. J Innov Card Rhythm Manag. 2018;9(2):3035-49.
Nabati M, Dehghan Z, Kalantari B, Yazdani J. Corrected QT interval prolongations in patients with non-st-elevation acute coronary syndrome. J Tehran Heart Cent. 2018;13(4):173-9.
Gadaleta FL, Llois SC, Sinisi VA, Quiles J, Avanzas P, Kaski JC. [Corrected QT interval prolongation: a new predictor of cardiovascular risk in patients with non-ST-elevation acute coronary syndrome]. Rev Esp Cardiol. 2008;61(6):572-8.
Jubeh R, Tzivoni D, Moriel M, et al. Patients with NSTEMI have increased QT prolongation as compared to patients with acute coronary syndrome without MI. European Heart Journal. 2013;34(suppl_1).
Gordon SS, Hollowed J, Hayase J, Macias C, Wang J, Middlekauff HR. Acquired long qt syndrome after acute myocardial infarction: A rare but potentially fatal entity. Tex Heart Inst J. 2020;47(2):163-4.
Locati EH, Zareba W, Moss AJ, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998;97(22):2237-44.
Awamleh García P, Alonso Martín JJ, Graupner Abad C, et al. Prevalence of electrocardiographic patterns associated with sudden cardiac death in the spanish population aged 40 years or older. Results of the OFRECE Study. Rev Esp Cardiol (Engl Ed). 2017;70(10):801-7.
Asatryan B, Schaller A, Bartholdi D, Medeiros-Domingo A. Late-onset severe long QT syndrome. Ann Noninvasive Electrocardiol. 2018;23(4):e12517.
Adeel M, Sharif F, Galvin J, McPherson C. Unusual presentation of congenital long QT syndrome. Journal of the American College of Cardiology. 2018;71(11_Supplement):A2613-A.
Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome. Circulation: Arrhythmia and Electrophysiology. 2012;5(4):868-77.
Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18):1761-7.
Lawin D, Poudel MR, Lawrenz T, Stellbrink C. Case report of a patient with congenital long QT syndrome Type 2 presenting with electrical storm: do not judge a book by its cover! European Heart Journal - Case Reports. 2022;6(9).
Waddell-Smith KE, Skinner JR. Update on the diagnosis and management of familial long QT syndrome. Heart Lung Circ. 2016;25(8):769-76.
Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal. 2022;43(40):3997-4126.
Roden DM. Long-QT Syndrome. New England Journal of Medicine. 2008;358(2):169-76.
Khan Z. Polypharmacy-induced long QT syndrome in a patient with newly diagnosed acute myeloid leukaemia: A Case Report. Cureus. 2023;15(3):e36914.
Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932-63.
Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA). European Heart Journal. 2021;42(35):3427-520.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.